Search

6 results for “HAPV3

Hapvida Targets Higher Margin with NotreDame Saúde Premium Launch
MarketsJul 28

Hapvida Targets Higher Margin with NotreDame Saúde Premium Launch

Hapvida (HAPV3) is launching a premium health plan in August under the NotreDame Saúde brand, aiming for margin expansion.

Hapvida (HAPV3) Pivots to Premium Segment with August Launch of 'NotreDame Saúde'
PROMarketsJul 28

Hapvida (HAPV3) Pivots to Premium Segment with August Launch of 'NotreDame Saúde'

Brazil's Hapvida (HAPV3) is launching a premium health plan brand, 'NotreDame Saúde,' to target higher-margin clients and boost Average Ticket Per User.

Hapvida (HAPV3) Launches Premium 'NotreDame Saúde' Line, Pivoting From Verticalized Model
PROMarketsJul 28

Hapvida (HAPV3) Launches Premium 'NotreDame Saúde' Line, Pivoting From Verticalized Model

Hapvida's new premium plan targets high-income segment, offering access to top-tier hospitals like Einstein and Sírio-Libanês, breaking its traditional model.

Hapvida Decline Highlights Volatility Across B3 Stocks
Small CapsJul 28

Hapvida Decline Highlights Volatility Across B3 Stocks

Shares of Brazilian healthcare giant Hapvida dropped 5.25% on Monday, diverging from the broader Ibovespa as medical claims anxiety persists.

Hapvida (HAPV3) Pivots to Premium Segment with NotreDame Saúde to Boost Average Ticket
MarketsJul 28

Hapvida (HAPV3) Pivots to Premium Segment with NotreDame Saúde to Boost Average Ticket

Hapvida launches 'NotreDame Saúde' brand in August, focusing on high-margin premium plans to lift profitability, marking a shift in strategy.

Hapvida Premium Push Threatens Small-Cap Health Competitors
Small CapsJul 28

Hapvida Premium Push Threatens Small-Cap Health Competitors

Hapvida launches its NotreDame Saúde premium brand, shifting from its vertical model and heightening competitive pressure on niche Brazilian healthcare peers.